CLASS II Device recall · Reported 31 Aug 2016 · FDA Enforcement Report

NovaPACS versions 8.4.7 recalled by Novarad

Novarad is recalling NovaPACS versions 8.4.7, 8.5.3, and 8.5.6, distributed nationwide in the US. The recall was initiated on 12 Aug 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesVersions 8.4.7, 8.5.3, and 8.5.6
Quantity recalled90

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2659-2016
FDA event ID
74937
Recalling firm
Novarad, American Fork, UT
Classification
Class II
Status
Terminated
Recall initiated
12 Aug 2016
FDA classified
25 Aug 2016
Reported
31 Aug 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

12 Aug 2016Recall initiated by company
25 Aug 2016Classified by FDA+13 days
31 Aug 2016Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Novarad Corporation announces a voluntary field action for the NovaPACS versions 8.4.7, 8.5.3, and 8.5.6 due to a "pop-up screen" that was prematurely released.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

NovaPACS versions 8.4.7, 8.5.3, and 8.5.6. Distributed by Novarad Corporation. Picture archiving and communication system (PACS) Product Usage NovaPACS is a picture archiving and communication system software that retrieves, archives, distributes, and displays images and data from all common modalities. NovaPACS uses a variety of workstations, including a Technologist Workstation, Enterprise Radiologist Workstation, Cardio Viewer and Workstation, NovaMG Workstation, and NovaWeb Web Viewer. The NovaPACS software makes images and data available in digital format from all common modalities. The images are viewed on a computer monitor or portable device. NovaPACS tools/features include the following: window, level, zoom, pan, digital subtraction, ejection fraction, cross localization, note-taking ability, voice dictation, and other similar tools. It includes the capability to measure distance and image intensity values, such as standardized uptake value. NovaPACS displays measurement lines, annotations, regions of interest, and fusion blending control functionality. Advanced features include 3D image rendering, virtual colonoscopy, and vessel analysis. Images and data are stored on a digital archive with multiple redundancies; images and data are available on-site and offsite. Novarad provides all software, including third party software (i.e. Windows¿ OS). NovaPACS software resides on third party hardware, which may vary depending on the client s PACS needs. All hardware is connected to the radiology department local area network. NovaPACS integrates with NovaRIS and may integrate with any other third party RIS software that has HL7 interface capabilities. NovaPACS is intended for the viewing, archiving, analysis, annotation, registration, distribution, editing, fusion, and processing of digital medical images and data acquired from diagnostic imaging devices and all DICOM devices, etc. NovaPACS is intended for use by trained healthcare professionals, including radiologists, physicians, technologists, clinicians, and nurses. NovaPACS allows the end user to display, manipulate, archive, and evaluate images. NovaPACS is not intended for diagnostic image review on a mobile platform. While NovaPACS provides tools to assist the healthcare professional determine diagnostic viability, it is the user's responsibility to ensure quality, display contrast, ambient light conditions, and to confirm image compression ratios are consistent with the generally accepted standards of the clinical application

Where it was distributed

Worldwide Distribution - US (Nationwide) Canada and other foreign consignees.

Nationwide

Questions about this recall

Why was it recalled?

Novarad Corporation announces a voluntary field action for the NovaPACS versions 8.4.7, 8.5.3, and 8.5.6 due to a "pop-up screen" that was prematurely released.

Which lots are affected?

Versions 8.4.7, 8.5.3, and 8.5.6

Where was it sold?

Worldwide Distribution - US (Nationwide) Canada and other foreign consignees.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Novarad

All 4
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IINovaPACS Diagnostic Viewer recalled by NovaradNovaradLabeling ErrorsNationwide
DeviceCLASS IINovaPACS  versions 7.4, 7.5, 7.6, and 8.0, Diagnostic Viewer recalledNovaradOtherNationwide
DeviceCLASS IINovaPACS  Diagnostic Viewer versions 8.3.7, 8.4.2 recalled by NovaradNovaradOtherNationwide

Other Heart & Vascular Devices recalls

All 6,199